Detection of carbapenemase producing Acinetobacter baumannii ST19 from Georgia and Ukraine carrying bla OXA-23 , bla OXA-72 , and/or bla NDM-5 , December 2019 to June 2023.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE
    • Publication Information:
      Publication: Stockholm, Sweden : European Centre for Disease Prevention and Control (ECDC)
      Original Publication: Saint-Maurice : Hôpital national de Saint-Maurice
    • Subject Terms:
    • Abstract:
      In 2003-2023, amid 5,436 Acinetobacter baumannii isolates collected globally through the Multidrug-Resistant Organism Repository and Surveillance Network, 97 were ST19PAS, 34 of which carbapenem-resistant. Strains (n = 32) sampled after 2019 harboured either bla OXA-23 , bla OXA-72 , and/or bla NDM-5 . Phylogenetic analysis of the 97 isolates and 11 publicly available ST19 genomes revealed three sub-lineages of carbapenemase-producing isolates from mainly Ukraine and Georgia, including an epidemic clone carrying all three carbapenemase genes. Infection control and global surveillance of carbapenem-resistant A. baumannii remain important.
    • References:
      J Hosp Infect. 2016 Jan;92(1):19-26. (PMID: 26615460)
      Lancet Infect Dis. 2012 Aug;12(8):587-8. (PMID: 22835896)
      Microbiol Spectr. 2023 Jun 15;11(3):e0046223. (PMID: 37140387)
      mBio. 2024 Feb 14;15(2):e0286723. (PMID: 38231533)
      J Antimicrob Chemother. 2011 Nov;66(11):2484-91. (PMID: 21873287)
      IUBMB Life. 2011 Dec;63(12):1061-7. (PMID: 21990280)
      J Glob Antimicrob Resist. 2020 Jun;21:363-368. (PMID: 31730823)
      Microbiol Spectr. 2023 Feb 14;11(1):e0247822. (PMID: 36472426)
      PeerJ. 2023 Feb 7;11:e14831. (PMID: 36778153)
      Microb Genom. 2019 Oct;5(10):. (PMID: 31599224)
      Future Microbiol. 2019 Oct;14:1281-1292. (PMID: 31638422)
      Antimicrob Agents Chemother. 2020 Sep 21;64(10):. (PMID: 32718956)
      Microorganisms. 2023 Aug 06;11(8):. (PMID: 37630581)
      J Antimicrob Chemother. 2015 Aug;70(8):2409-11. (PMID: 25881617)
      Clin Microbiol Infect. 2012 Mar;18(3):268-81. (PMID: 21793988)
      PLoS One. 2010 Apr 07;5(4):e10034. (PMID: 20383326)
      Front Microbiol. 2022 Jul 22;13:878912. (PMID: 35935207)
      mBio. 2021 Oct 26;12(5):e0206021. (PMID: 34517763)
      Clin Microbiol Infect. 2006 Sep;12(9):826-36. (PMID: 16882287)
      Lancet Infect Dis. 2011 Jan;11(1):8-10. (PMID: 21183141)
      Clin Infect Dis. 2023 Jul 18;:. (PMID: 37463564)
    • Contributed Indexing:
      Keywords: A. baumannii; Acinetobacter baumannii; NDM; antimicrobial resistance; carbapenem resistance; microbial genomics; molecular epidemiology; nosocomial outbreak; surveillance
    • Accession Number:
      EC 3.5.2.6 (beta-Lactamases)
      EC 3.5.2.6 (carbapenemase)
      0 (Bacterial Proteins)
      0 (Anti-Bacterial Agents)
      0 (Carbapenems)
      EC 3.5.2.6 (OXA-72 carbapenemase, Acinetobacter baumannii)
      EC 3.5.2.- (beta-lactamase OXA-23)
    • Publication Date:
      Date Created: 20240614 Date Completed: 20240614 Latest Revision: 20240616
    • Publication Date:
      20240616
    • Accession Number:
      PMC11177571
    • Accession Number:
      10.2807/1560-7917.ES.2024.29.24.2400259
    • Accession Number:
      38873796